Press release
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Share, Trends, Growth And Outlook By 2033
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Share
As per the report, the hypertrophic cardiomyopathy (hcm) therapeutics market size has grown steadily in recent years. It will grow from $1.3 billion in 2023 to $1.34 billion in 2024 at a compound annual growth rate (CAGR) of 2.7%. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.48 billion in 2028 at a compound annual growth rate (CAGR) of 2.6%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=9914&type=smp
Rising Incidence Of Cardiovascular Diseases Fuels Growth In Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
The increasing incidence of cardiovascular diseases (CVD) is expected to propel the growth of the hypertrophic cardiomyopathy (HCM) therapeutics market. Cardiovascular disease (CVD) is a condition that affects the heart or blood vessels. Cardiovascular diseases include heart irregularities such as atrial fibrillation, ventricular fibrillation, and atrioventricular block that require long-term monitoring. The primary need for therapeutics treatment for hypertrophic cardiomyopathy aims to alleviate symptoms and avoid sudden cardiac death in high-risk patients. For instance, according to the October 2022 report of the Center For Disease Control and Prevention (CDCP), a US-based national public health agency, in the United States, one person dies from cardiovascular disease every 36 seconds, and CVD is responsible for nearly 836,546 deaths in the United States alone in 2021. Therefore, the increasing incidence of cardiovascular diseases (CVD) drives the hypertrophic cardiomyopathy (HCM) therapeutics market.
Innovative Products Drive Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Product innovations are the key trend gaining popularity in the hypertrophic cardiomyopathy (HCM) therapeutics market. Major companies operating in the cardiomyopathy therapeutics sector are focused on developing new innovative products to strengthen their position in the market. For instance, in April 2022, Bristol Myers Squibb, a US-based biopharmaceutical company, launched Camzyos (mavacamten), an oral small-molecule cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy (HCM) and diseases of heart diastolic dysfunction. Camzyos (mavacamten) was approved by the US Food and Drug Administration (FDA) for the treatment of adults with symptomatic class II-III obstructive hypertrophic cardiomyopathy (obstructive HCM) to improve functional capacity and symptoms. Camzyos is the first and only FDA-approved allosteric and reversible inhibitor of cardiac myosin that targets the underlying pathophysiology of obstructive HCM. Camzyos controls the number of myosin heads that can enter ""on actin"" (power-generating) states.
The hypertrophic cardiomyopathy (hcm) therapeutics market covered in this report is segmented -
1) By Drug Type: Antiarrhythmic Agents, Anticoagulants, Beta Adrenergic Blocking Agents, Calcium Channel Blockers, Other Drug Types
2) By Device Type: Defibrillators, Pacemakers, Other Device Types
3) By End User: Hospitals, Clinics
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9914&type=discount
Major companies operating in the hypertrophic cardiomyopathy (hcm) therapeutics market report are Merck & Co. Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc, Gilead Sciences Inc., Bayer AG, Correvio Pharma Corp., Abbott Laboratories Inc., Advanz Pharma Corp., Lupin Limited, Myokardia Inc., Boston Scientific Corporation, Bristol-Myers Squibb Company, Johnson & Johnson, Medtronic plc, Mylan N.V., Cardiome Pharma Corp., Cytokinetics Inc., Daiichi Sankyo Company Limited, GlaxoSmithKline plc., HUYA Bioscience International LLC, Ionis Pharmaceuticals Inc., Janssen Pharmaceuticals Inc., Kowa Company Ltd., Luitpold Pharmaceuticals Inc., Menarini Group, Mitsubishi Tanabe Pharma Corporation, Nippon Shinyaku Co. Ltd., Otsuka Holdings Co. Ltd., Servier Laboratories, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited .
Contents of the report:
1. Executive Summary
2. Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report Structure
3. Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Trends And Strategies
4. Hypertrophic Cardiomyopathy (HCM) Therapeutics Market - Macro Economic Scenario
5. Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size And Growth
…..
27. Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/hypertrophic-cardiomyopathy-hcm-therapeutics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Share, Trends, Growth And Outlook By 2033 here
News-ID: 3601863 • Views: …
More Releases from The Business research company
Emerging Trends to Reshape the Global Fitness App Market: Revolutionizing Person …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Fitness App Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The scale of the fitness app market has seen significant expansion in the past few years. It's projected to accelerate from a value of $14.66 billion in 2024 to a staggering $17.71 billion in 2025,…
2025-2034 Enterprise Quantum Computing Market Evolution: Disruptions, Innovation …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Enterprise Quantum Computing Market Through 2025?
The market size of enterprise quantum computing has seen rapid expansion in the past few years. It is projected to escalate from $3.76 billion in 2024 to an impressive $4.78 billion in 2025, exhibiting a compound…
Global Emotion Detection And Recognition Market Projected to Grow at 16.1% CAGR, …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Emotion Detection And Recognition Industry Market Size Be by 2025?
The market size of emotion detection and recognition has seen a swift growth in the recent years. It is projected to expand from $27.64 billion in 2024 to $31.19 billion in 2025, with a Compound Annual…
Global Digital Transformation Industry Outlook 2025-2029: Market Set to Cross $4 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Digital Transformation Market Size By 2025?
The rapid expansion of the digital transformation market in recent years has been notable. The market, which was valued at $1755.44 billion in 2024, is set to climb to a staggering $2105.59 billion in 2025, reflecting a compound annual…
More Releases for HCM
Evolving Market Trends In The Hypertrophic Cardiomyopathy (HCM) Therapeutics Ind …
The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size and Its Estimated Growth Rate?
In the past few years, the hypertrophic cardiomyopathy (HCM) therapeutics market has seen a minor increase in its…
Evolving Market Trends In The Hypertrophic Cardiomyopathy (HCM) Therapeutics Ind …
The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size and Its Estimated Growth Rate?
In the past few years, the hypertrophic cardiomyopathy (HCM) therapeutics market has seen a minor increase in its…
Human Capital Management (HCM) Market Study Navigating the Future Growth Outlook …
This global Human Capital Management (HCM) Market market research report is a proven and consistent source of information which gives telescopic view of the existing market trends, emerging products, situations and opportunities that drive business towards success. Market segmentation studies conducted in this report with respect to product type, applications, and geography are valuable in taking any verdict about the products. Gaining valuable market insights with the new skills, latest…
Human Capital Management (HCM) Market to Witness Huge Growth by 2019-2025 | Ceri …
A new business intelligence report released by HTF MI with title “Global Human Capital Management (HCM) Market 2019-2025” that targets and provides comprehensive market analysis with future prospects to 2025. The rapid decision-making power of market research and consumer insight is never more valuable than in times of crisis. The analysts of the study have utilized extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to…
Human Capital Management (HCM) Market to see Booming Worldwide | Ceridian HCM, O …
A qualitative research study accomplished by HTF MI titled “Global Human Capital Management (HCM) Market covers detailed Product / Industry Scope, current and future market size scenario and elaborates outlook and status to 2025” provides primary data, studies and vendor briefings. The market Study is segmented by key regions along with country level break-up which is accelerating the marketization and by products type, application/end-users. The research study provides estimates for…
Human Capital Management (HCM) & Payroll - Great Market, Know Players Growth Rat …
The Exploration study offers deep assessment of the Global Human Capital Management (HCM) & Payroll Market and helps market participants to gain a solid base in the industry. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, historical data, facts and statistically supported and industry certified market data. It delivers regional exploration of the Global Human Capital Management (HCM) &…
